Insiders · PRME

PRME insider transactions

Prime Medicine Inc. (PRME) Form 4 insider transactions - real-time wire coverage of every officer, director, and 10% owner trade.

PRME insiders

Everyone who has filed a Form 4 or 5 at Prime Medicine Inc., latest first. Follow anyone to get their next filing.

• David P SchenkeinDirector
• Jeffrey D MarrazzoDirector
• Robert NelsenDirector, 10% owner+$20M
• Michael Aaron KellyDirector
• Kaye I Foster-CheekDirector
• Wendy ChungDirector
• Thomas CahillDirector
• Svetlana Ni MakhniChief Financial Officer
• Allan ReineChief Executive Officer, Director+$147K
• Ann L. LeeChief Technical Officer+$113K
• Carman AlensonOfficer
• Gv 2021 Gp, L.L.C.10% owner+$4.95M
• ARCH Venture Partners XII, LLC10% owner+$30M
• ARCH Venture Partners X, LLC10% owner+$30M
• David R. Liu10% owner+$163K
• Richard BrudnickChief Business Officer+$23.8K
• Keith Michael GottesdienerOfficer, Director
• Meredith GoldwasserSVP, Strategy & Corporate Ops.
• Jeremy DuffieldChief Scientific Officer
• Gv 2019 Gp, L.L.C.10% owner+$13.6M-$20M

Recent Form 3, 4, and 5 filings for PRME

• 151d
  SEC Form 4 filed by Director Schenkein David P

  4 - Prime Medicine, Inc. (0001894562) (Issuer)
• 151d
  SEC Form 4 filed by Director Marrazzo Jeffrey D

  4 - Prime Medicine, Inc. (0001894562) (Issuer)
• 151d
  SEC Form 4 filed by Director Nelsen Robert

  4 - Prime Medicine, Inc. (0001894562) (Issuer)
• 151d
  SEC Form 4 filed by Director Kelly Michael Aaron

  4 - Prime Medicine, Inc. (0001894562) (Issuer)
• 151d
  SEC Form 4 filed by Director Foster-Cheek Kaye I

  4 - Prime Medicine, Inc. (0001894562) (Issuer)
• 151d
  SEC Form 4 filed by Director Chung Wendy

  4 - Prime Medicine, Inc. (0001894562) (Issuer)
• 151d
  SEC Form 4 filed by Director Cahill Thomas

  4 - Prime Medicine, Inc. (0001894562) (Issuer)
• 202d
  SEC Form 4 filed by Makhni Svetlana Ni

  4 - Prime Medicine, Inc. (0001894562) (Issuer)
• 202d
  SEC Form 3 filed by new insider Makhni Svetlana Ni

  3 - Prime Medicine, Inc. (0001894562) (Issuer)
• 252d
  SEC Form 4 filed by Chief Executive Officer Reine Allan

  4 - Prime Medicine, Inc. (0001894562) (Issuer)
• 255d
  SEC Form 4 filed by Chief Technical Officer Lee Ann L.

  4 - Prime Medicine, Inc. (0001894562) (Issuer)
• 255d
  SEC Form 4 filed by Officer Alenson Carman

  4 - Prime Medicine, Inc. (0001894562) (Issuer)
• 457d
  SEC Form 4 filed by Chief Technical Officer Lee Ann L.

  4 - Prime Medicine, Inc. (0001894562) (Issuer)
• 457d
  SEC Form 4 filed by Director Schenkein David P

  4 - Prime Medicine, Inc. (0001894562) (Issuer)
• 457d
  SEC Form 4 filed by Director Nelsen Robert

  4 - Prime Medicine, Inc. (0001894562) (Issuer)
• 457d
  SEC Form 4 filed by Director Marrazzo Jeffrey D

  4 - Prime Medicine, Inc. (0001894562) (Issuer)
• 457d
  SEC Form 4 filed by Director Kelly Michael Aaron

  4 - Prime Medicine, Inc. (0001894562) (Issuer)
• 457d
  SEC Form 4 filed by Director Foster-Cheek Kaye I

  4 - Prime Medicine, Inc. (0001894562) (Issuer)
• 457d
  SEC Form 4 filed by Director Chung Wendy

  4 - Prime Medicine, Inc. (0001894562) (Issuer)
• 457d
  SEC Form 4 filed by Director Cahill Thomas

  4 - Prime Medicine, Inc. (0001894562) (Issuer)
• 457d
  SEC Form 4 filed by Officer Alenson Carman

  4 - Prime Medicine, Inc. (0001894562) (Issuer)
• 457d
  SEC Form 4 filed by Chief Executive Officer Reine Allan

  4 - Prime Medicine, Inc. (0001894562) (Issuer)
• 458d
  Large owner Gv 2021 Gp, L.L.C. bought $4,950,000 worth of shares (1,500,000 units at $3.30) (SEC Form 4)

  4 - Prime Medicine, Inc. (0001894562) (Issuer)
• 461d
  Director Nelsen Robert bought $9,999,990 worth of shares (3,030,300 units at $3.30) (SEC Form 4)

  4 - Prime Medicine, Inc. (0001894562) (Issuer)
• 461d
  Large owner Arch Venture Partners Xii, Llc bought $9,999,990 worth of shares (3,030,300 units at $3.30) (SEC Form 4)

  4 - Prime Medicine, Inc. (0001894562) (Issuer)
• 461d
  Large owner Arch Venture Partners X, Llc bought $9,999,990 worth of shares (3,030,300 units at $3.30) (SEC Form 4)

  4 - Prime Medicine, Inc. (0001894562) (Issuer)
• 493d
  Large owner Liu David R. bought $52,830 worth of shares (21,000 units at $2.52), increasing direct ownership by 0.10% to 20,240,945 units (SEC Form 4)

  4 - Prime Medicine, Inc. (0001894562) (Issuer)
• 501d
  Large owner Liu David R. bought $45,402 worth of shares (21,000 units at $2.16), increasing direct ownership by 0.10% to 20,219,945 units (SEC Form 4)

  4 - Prime Medicine, Inc. (0001894562) (Issuer)
• 508d
  Large owner Liu David R. bought $31,196 worth of shares (21,000 units at $1.49), increasing direct ownership by 0.10% to 20,198,945 units (SEC Form 4)

  4 - Prime Medicine, Inc. (0001894562) (Issuer)
• 512d
  Large owner Liu David R. bought $33,590 worth of shares (21,000 units at $1.60), increasing direct ownership by 0.10% to 20,177,945 units (SEC Form 4)

  4 - Prime Medicine, Inc. (0001894562) (Issuer)
• 519d
  SEC Form 4 filed by Director Schenkein David P

  4 - Prime Medicine, Inc. (0001894562) (Issuer)
• 519d
  SEC Form 4 filed by Director Marrazzo Jeffrey D

  4 - Prime Medicine, Inc. (0001894562) (Issuer)
• 519d
  SEC Form 4 filed by Director Nelsen Robert

  4 - Prime Medicine, Inc. (0001894562) (Issuer)
• 519d
  SEC Form 4 filed by Director Kelly Michael Aaron

  4 - Prime Medicine, Inc. (0001894562) (Issuer)
• 519d
  SEC Form 4 filed by Director Foster-Cheek Kaye I

  4 - Prime Medicine, Inc. (0001894562) (Issuer)
• 519d
  SEC Form 4 filed by Director Chung Wendy

  4 - Prime Medicine, Inc. (0001894562) (Issuer)
• 519d
  SEC Form 4 filed by Director Cahill Thomas

  4 - Prime Medicine, Inc. (0001894562) (Issuer)
• 533d
  Chief Business Officer Brudnick Richard bought $23,790 worth of shares (20,000 units at $1.19) (SEC Form 4)

  4 - Prime Medicine, Inc. (0001894562) (Issuer)
• 533d
  Chief Technical Officer Lee Ann L. bought $113,000 worth of shares (100,000 units at $1.13) (SEC Form 4)

  4 - Prime Medicine, Inc. (0001894562) (Issuer)
• 533d
  Chief Executive Officer Reine Allan bought $147,150 worth of shares (125,000 units at $1.18) (SEC Form 4)

  4 - Prime Medicine, Inc. (0001894562) (Issuer)
• 535d
  SEC Form 4 filed by Director Marrazzo Jeffrey D

  4 - Prime Medicine, Inc. (0001894562) (Issuer)
• 535d
  SEC Form 4 filed by Chief Executive Officer Reine Allan

  4 - Prime Medicine, Inc. (0001894562) (Issuer)
• 543d
  SEC Form 4 filed by Chief Financial Officer Reine Allan

  4 - Prime Medicine, Inc. (0001894562) (Issuer)
• 543d
  SEC Form 4 filed by Officer Gottesdiener Keith Michael

  4 - Prime Medicine, Inc. (0001894562) (Issuer)
• 543d
  SEC Form 4 filed by Chief Technical Officer Lee Ann L.

  4 - Prime Medicine, Inc. (0001894562) (Issuer)
• 612d
  SEC Form 4 filed by Officer Gottesdiener Keith Michael

  4 - Prime Medicine, Inc. (0001894562) (Issuer)
• 612d
  SEC Form 4 filed by Officer Alenson Carman

  4 - Prime Medicine, Inc. (0001894562) (Issuer)
• 612d
  SEC Form 4 filed by SVP, Strategy & Corporate Ops. Goldwasser Meredith

  4 - Prime Medicine, Inc. (0001894562) (Issuer)
• 612d
  SEC Form 4 filed by Chief Scientific Officer Duffield Jeremy

  4 - Prime Medicine, Inc. (0001894562) (Issuer)
• 612d
  SEC Form 4 filed by Chief Technical Officer Lee Ann L.

  4 - Prime Medicine, Inc. (0001894562) (Issuer)
• 612d
  SEC Form 4 filed by Chief Business Officer Brudnick Richard

  4 - Prime Medicine, Inc. (0001894562) (Issuer)
• 612d
  SEC Form 4 filed by Chief Financial Officer Reine Allan

  4 - Prime Medicine, Inc. (0001894562) (Issuer)
• 696d
  SEC Form 4 filed by Officer Gottesdiener Keith Michael

  4 - Prime Medicine, Inc. (0001894562) (Issuer)
• 696d
  SEC Form 4 filed by Chief Business Officer Brudnick Richard

  4 - Prime Medicine, Inc. (0001894562) (Issuer)
• 696d
  SEC Form 4 filed by Chief Financial Officer Reine Allan

  4 - Prime Medicine, Inc. (0001894562) (Issuer)
• 757d
  Officer Gottesdiener Keith Michael gifted 226,925 shares and received a gift of 226,925 shares (SEC Form 4)

  4 - Prime Medicine, Inc. (0001894562) (Issuer)
• 875d
  SEC Form 4 filed by Director Marrazzo Jeffrey D

  4 - Prime Medicine, Inc. (0001894562) (Issuer)
• 875d
  SEC Form 4 filed by Director Schenkein David P

  4 - Prime Medicine, Inc. (0001894562) (Issuer)
• 875d
  SEC Form 4 filed by Director Nelsen Robert

  4 - Prime Medicine, Inc. (0001894562) (Issuer)
• 875d
  SEC Form 4 filed by Director Chung Wendy

  4 - Prime Medicine, Inc. (0001894562) (Issuer)